Abstract
SELECTIVE antagonism of serotonin (5-hydroxytryptamine, 5HT) and noradrenaline transport by antidepressants is a key element in the 'amine' hypothesis of affective disorders1. Uptake2,3 and/or transport sites4,5 of 5HT have been reported to be reduced in platelets of patients suffering from depression and in post-mortem brain samples of depressed patients6 and suicide victims7. To date there has been little molecular information available on the structure and regulation of 5HT transporters. Using the polymerase chain reaction8with degenerate oligonucleotides9 derived from two highly conserved regions of the transporters for noradrenaline10 and γ-aminobutyric acid11(GABA), we have identified a large family of related gene products expressed in rodent brain. One of these products hybridizes to a single 3.7-kilobase RNA restricted to rat midbrain and brainstem, where it is highly enriched within the serotonergic raphe complex. Transfection with a single 2.3-kilobase brainstem complementary DNA clone is sufficient to confer expression of a Na+-dependent 5HT transporter upon non-neural cells, with transport selectively and potently antagonized by 5HT uptake-specific antidepressants, including paroxetine, citalopram and fluoxetine.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ashton, H. Brain Systems, Disorders and Psychotropic Drugs 283–330 (Oxford University Press, New York, 1987).
Meltzer, H. Y., Arora, R. C., Baber, R. & Tricou, B. J. Arch. gen. Psychiat. 38, 1322–1326 (1981).
Suranyi-Cadotte, B. E., Quiron, R., Nair, N. P. V., Lafaille, F. & Schwartz, G. Life Sci. 36, 795–799 (1985).
Briley, M. S., Langer, S. Z., Raisman, R., Sechter, D. & Zarifan, E. Science 209, 303–305 (1980).
Paul, S. M., Rehavi, M., Skolnick, P., Ballenger, J. C. & Goodwin, F. K. Arch. gen. Psychiat. 38, 1315–1317 (1981).
Perry, E. K., Marshall, E. F., Blessed, G., Tomlinson, B. E. & Perry, R. H. Brit. J. Psychiat. 142, 188–192 (1983).
Stanley, M., Virgilio, J. & Gershon, S. Science 216, 1337–1339 (1982).
Saiki, R. K. et al. Science 239, 487–494 (1988).
Rathe, R. J. molec. Biol. 183, 1–12 (1985).
Pacholczyk, T., Blakely, R. D. & Amara, S. G. Nature 350, 350–354 (1991).
Guastella, J. et al. Science 249, 1303–1306 (1990).
Richelson, E. Mayo Clin. Proc. 65, 1227–1236 (1990).
Fremeau, R. T. Jr et al. Proc. natn. Acad. Sci. U.S.A. 88, 3772–3776 (1991).
Steinbusch, H. W. M. & Niewenhuys, R. in Chemical Neuroanatomy (ed. Emson, P. C.) 131–207 (Raven, New York, 1983).
Hinson, J. P., Vinson, G. P., Pudney, J. & Whitehouse, B. J. J. Endocr. 121, 253–260 (1989).
Verhofstad, A. A. J. & Jonsson, G. Neuroscience 10, 1443–1453 (1983).
Holzworth, M. A. & Brownfield, M. S. Neuroendocrinology 41, 230–236 (1985).
Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual 2nd edn (Cold Spring Harbor Laboratory, New York, 1989).
Maxwell, R. A. & White, H. L. in Handbook of Psychopharmacology (eds Iversen, L. L., Iversen, S. D. & Snyder, S. H.) 83–155 (Plenum, New York, 1978).
Lemberger, L. H. et al. Clin. Pharmac. Ther. 23, 421–429 (1978).
Hyttel, J. Psychopharmacology 51, 225–233 (1977).
Buss Lassen, J. Eur. J. Pharmac. 47, 351–358 (1978).
Ritz, M. C., Cone, E. J. & Kuhar, M. J. Life Sci. 46, 635–645 (1990).
Kozak, M. Nucleic Acids Res. 15, 8125–8148 (1987).
Kyte, J. & Doolittle, R. F. J. molec. Biol. 157, 105–132 (1982).
Nelson, H., Mandiyan, S. & Nelson, N. FEBS Lett. 269, 181–184 (1990).
von Heijne, G. Eur. J. Biochem. 133, 17–21 (1983).
Kemp, B. E. & Pearson, R. B. Trends. biochem. Sci. 15, 342–346 (1990).
Cool, D. R., Leibach, F. H., Bhalla, V., Maheshi, V. & Ganapathy, V. J. biol. Chem. 266, 15750–15757 (1991).
Devereux, J., Haeberli, P. & Smithies, O. Nucleic Acids Res. 12, 387–395 (1984).
Andersen, P. H. Eur. J. Pharmac. 166, 493–504 (1989).
Graham, D., Esnaud, H., Habert, E. & Langer, S. Z. Biochem. Pharmac. 38, 3819–3826 (1989).
Marcusson, J. O., Andersson, A. & Bäckström, I. Psychopharmacology 99, 17–21 (1989).
Koe, B. K. J. Pharmac. exp. Ther. 199, 649–661 (1976).
Strader, C. D., Sigal, I. S. & Dixon, R. A. F. FASEB J. 3, 1825–1832 (1989).
Kobilka, B. K. et al. Science 240, 1310–1316 (1988).
Fuller, R. W. & Wong, D. T. Ann. N.Y. Acad. Sci. 600, 69–80 (1990).
Fuerst, T. R., Niles, E. G., Studier, F. W. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 83, 8122–8126 (1986).
Blakely, R. D., Clark, J. A., Pacholczyk, T. & Amara, S. G. Analyt. Biochem. 194, 302–308 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blakely, R., Berson, H., Fremeau , R. et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66–70 (1991). https://doi.org/10.1038/354066a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/354066a0
This article is cited by
-
High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin
Molecular Psychiatry (2024)
-
The monoaminergic system is a bilaterian innovation
Nature Communications (2023)
-
Forty Four Years With Baruch Kanner and The Chloride Ion
Neurochemical Research (2022)
-
Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo
Neurochemical Research (2022)
-
Multiplex and on-site PCR detection of swine diseases based on the microfluidic chip system
BMC Veterinary Research (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.